-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QgzbZTsrhiC2G/C8zkMYoNfpYYGVHL5pi89kM1l5RAH5gdIuYyTWnSnXr4Smoahe zLhigfi5LeNzyUXfcoDVWg== 0000000000-10-003050.txt : 20100301 0000000000-10-003050.hdr.sgml : 20100301 20100119093402 ACCESSION NUMBER: 0000000000-10-003050 CONFORMED SUBMISSION TYPE: UPLOAD PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20100119 FILED FOR: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: UPLOAD BUSINESS ADDRESS: STREET 1: 2273 RESEARCH BLVD, SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: (301) 795-1800 MAIL ADDRESS: STREET 1: 2273 RESEARCH BLVD, SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 PUBLIC REFERENCE ACCESSION NUMBER: 0001367644-09-000009 LETTER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C0-)>+CS],-"C8@,"!O8FH-/#PO3&EN96%R:7IE9"`Q+TP@-S4X M-"]/(#@O12`S,S,T+TX@,2]4(#7!E+T-A=&%L M;V7!E+U!A9V4^/@UE;F1O8FH-.2`P(&]B:@T\/"]&;VYT/#PO5%0R(#$P M(#`@4B]45#0@,3(@,"!2/CXO4')O8U-E=%LO4$1&+U1E>'1=+T5X=$=3=&%T M93P\+T=3,2`Q-2`P(%(^/CX^#65N9&]B:@TQ,"`P(&]B:@T\/"]3=6)T>7!E M+U1R=654>7!E+T9O;G1$97-C\I#*^X]K#MMN M=I'/WN>Y``YY->,"&+YQ63)(64:7"\CW,P9;_.2E^7J<$0CR7VB&G/($\DM_ MD+_["\-Y,^M.&6.I00^]]3C[3KZJ`JZ*LE/[(*,)4;6$HMG`OW1-X:90-00_ M\FL'PY8&Y8B??;[NVWN(4\&>X['E$=TC5Q,V,NZ"IO'2$X"`#RW5D($X^R$43*A-`UY7(78'-C.\UHVJM7P5942;K7LU$8V04(7I(?P8:>D9[@HAUJ^5#HS1S6@^HEQ.REP">U MB;BC<->6OQ]476,);E#"VJ0B;'%8EK"W&%A\G)'8S)S$(QE+HB@R7//O2;[NMS)#=88>'P.%8[= M!L[O-83V1R:C:'I%\%.A0V^- MN1H-X;]@B8)*E#4EL"L>))3M_KZ6/5:O'31H^:#D([05/.'631_>K0C-_BUV*$'/V%_F$ECF0!-"]6@ ML7NT8>L'M.D1L<>>4AWTRA]B7AGQ78HW^+2,]E(?+;Q";9V^CUP^B7!?CQY/SF/NEE,F+_]B1@X'"O:!B-\L"+EN M90VWA?X]WFS'#B/DV.7^=6X("7!E+U1R=654>7!E+T9O;G1$97-C M2A4:6UE M7!E+T5X=$=3=&%T92]302!F86QS92]332`P+C`R/CX-96YD M;V)J#3$@,"!O8FH-/#PO3G5MFMC.60B/SX* M/'@Z>&UP;65T82!X;6QN#IX;7!T:STB M061O8F4@6$U0($-O&UL;G,Z9&,](FAT='`Z+R]P=7)L+F]R9R]D8R]E;&5M96YT"UD969A M=6QT(CY-:6-R;W-O9G0@5V]R9"`M($5M97)G96YT($)I;U-O;'5T:6]N&%P34TZ26YS=&%N8V5)1#YU M=6ED.C&%P M34TZ26YS=&%N8V5)1#X*("`@("`@/"]R9&8Z1&5S8W)I<'1I;VX^"B`@(#PO M')E9@T*,3$V#0HE)45/1@T* ` end -----END PRIVACY-ENHANCED MESSAGE-----